By JAN HOFFMAN
The drugmaker will pay $10 million in the case, plus additional contributions worth $10.4 million, to avoid going to trial in two Ohio counties for its role in the crisis.
Published: September 30, 2019 at 08:00PM
from NYT Health https://ift.tt/2nrLBm9
via IFTTT
from WordPress https://ift.tt/2oqU0pM
via IFTTT
No comments:
Post a Comment